Home / Author Archives: GlobeNewswire (page 2)
Author Archives: GlobeNewswire
Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program
Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update
AB-729, our RNAi therapeutic, provided robust and comparable HBsAg declines in both HBeAg+ and HBeAg- patients 50% (16 out of 32) of patients maintained HBsAg levels below 100 IU/mL 24 weeks after their last AB-729 dose In the first five ...
Read More »